RGAG CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. RGAG Gen Silencer sind erhältlich als RGAG CRISPR/Cas9 Knockout Plasmide und RGAG Double Nickase Plasmide. RGAG CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
RGAG CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RGAG1 CRISPR/Cas9 KO Plasmid (h) | sc-412823 | h | Gene Knockout | GFP | 0 | ||
RGAG1 HDR Plasmid (h) | sc-412823-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RGAG1 Double Nickase Plasmid (h) | sc-412823-NIC | h | Gene Knockout | Puromycin | 0 | ||
RGAG1 Double Nickase Plasmid (h2) | sc-412823-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RGAG1 CRISPR/Cas9 KO Plasmid (m) | sc-431646 | m | Gene Knockout | GFP | 0 | ||
RGAG1 HDR Plasmid (m) | sc-431646-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RGAG1 Double Nickase Plasmid (m) | sc-431646-NIC | m | Gene Knockout | Puromycin | 0 | ||
RGAG1 Double Nickase Plasmid (m2) | sc-431646-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
RGAG4 CRISPR/Cas9 KO Plasmid (h) | sc-415542 | h | Gene Knockout | GFP | 0 | ||
RGAG4 HDR Plasmid (h) | sc-415542-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RGAG4 Double Nickase Plasmid (h) | sc-415542-NIC | h | Gene Knockout | Puromycin | 0 | ||
RGAG4 Double Nickase Plasmid (h2) | sc-415542-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RGAG4 CRISPR/Cas9 KO Plasmid (m) | sc-436061 | m | Gene Knockout | GFP | 0 | ||
RGAG4 HDR Plasmid (m) | sc-436061-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RGAG4 Double Nickase Plasmid (m) | sc-436061-NIC | m | Gene Knockout | Puromycin | 0 | ||
RGAG4 Double Nickase Plasmid (m2) | sc-436061-NIC-2 | m | Gene Knockout | Puromycin | 0 |
RGAG CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RGAG1 CRISPR Activation Plasmid (h) | sc-412823-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG1 CRISPR Activation Plasmid (h2) | sc-412823-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG1 Lentiviral Activation Particles (h) | sc-412823-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG1 Lentiviral Activation Particles (h2) | sc-412823-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG1 CRISPR Activation Plasmid (m) | sc-431646-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG1 CRISPR Activation Plasmid (m2) | sc-431646-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG1 Lentiviral Activation Particles (m) | sc-431646-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG1 Lentiviral Activation Particles (m2) | sc-431646-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG4 CRISPR Activation Plasmid (h) | sc-415542-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG4 CRISPR Activation Plasmid (h2) | sc-415542-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG4 Lentiviral Activation Particles (h) | sc-415542-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG4 Lentiviral Activation Particles (h2) | sc-415542-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG4 CRISPR Activation Plasmid (m) | sc-436061-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG4 CRISPR Activation Plasmid (m2) | sc-436061-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG4 Lentiviral Activation Particles (m) | sc-436061-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RGAG4 Lentiviral Activation Particles (m2) | sc-436061-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |